1. Home
  2. CNC vs A Comparison

CNC vs A Comparison

Compare CNC & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNC
  • A
  • Stock Information
  • Founded
  • CNC 1984
  • A 1999
  • Country
  • CNC United States
  • A United States
  • Employees
  • CNC N/A
  • A N/A
  • Industry
  • CNC Medical Specialities
  • A Biotechnology: Laboratory Analytical Instruments
  • Sector
  • CNC Health Care
  • A Industrials
  • Exchange
  • CNC Nasdaq
  • A Nasdaq
  • Market Cap
  • CNC 31.2B
  • A 29.3B
  • IPO Year
  • CNC 2001
  • A 1999
  • Fundamental
  • Price
  • CNC $56.44
  • A $111.91
  • Analyst Decision
  • CNC Buy
  • A Buy
  • Analyst Count
  • CNC 15
  • A 14
  • Target Price
  • CNC $79.79
  • A $143.46
  • AVG Volume (30 Days)
  • CNC 5.1M
  • A 2.3M
  • Earning Date
  • CNC 07-25-2025
  • A 05-28-2025
  • Dividend Yield
  • CNC N/A
  • A 0.89%
  • EPS Growth
  • CNC 33.19
  • A N/A
  • EPS
  • CNC 6.72
  • A 4.06
  • Revenue
  • CNC $153,266,000,000.00
  • A $6,628,000,000.00
  • Revenue This Year
  • CNC $23.60
  • A $5.50
  • Revenue Next Year
  • CNC $0.61
  • A $5.98
  • P/E Ratio
  • CNC $8.40
  • A $27.56
  • Revenue Growth
  • CNC 7.22
  • A 0.56
  • 52 Week Low
  • CNC $55.03
  • A $96.43
  • 52 Week High
  • CNC $80.59
  • A $153.84
  • Technical
  • Relative Strength Index (RSI)
  • CNC 39.77
  • A 52.55
  • Support Level
  • CNC $55.73
  • A $107.07
  • Resistance Level
  • CNC $62.21
  • A $116.99
  • Average True Range (ATR)
  • CNC 1.75
  • A 2.74
  • MACD
  • CNC -0.52
  • A 0.19
  • Stochastic Oscillator
  • CNC 8.43
  • A 48.79

About CNC Centene Corporation

Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.

About A Agilent Technologies Inc.

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

Share on Social Networks: